Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin in migraine prophylaxis.

Hartmut Göbel1

  • 1Neurologisch-verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9-27, 24149 Kiel, Germany. hg@schmerzklinik.de

Journal of Neurology
|March 3, 2004
PubMed
Summary

Botulinum toxin type A offers a safe and effective new treatment for chronic migraine prevention. It significantly reduces migraine frequency, severity, and disability with minimal side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurologic Symptoms and Cerebrovascular Events During Atogepant Therapy: A Case Series with Contextual Comparison with a Non-Gepant-Treated Migraine Cohort.

Journal of clinical medicine·2026
Same author

How We Can Optimize Dysmenorrhea Treatment: Real-World Results from a Cross-Sectional, Multi-Center Study.

Geburtshilfe und Frauenheilkunde·2026
Same author

Prevalence of migraine subtypes in women with endometriosis and/or dysmenorrhea: results from a cross-sectional multicenter trial.

BMC women's health·2026
Same author

Evaluating Treatment Success in CGRP Antibody Prophylaxis: A Retrospective Cohort Study Comparing Monthly Migraine Days, MIDAS Scores, and HIT-6 Scores.

Pain and therapy·2025
Same author

Impact and care gaps of headache disorders in active-duty military personnel: A cross-sectional study from a European armed forces population.

Cephalalgia : an international journal of headache·2025
Same author

Headache Management in Military Primary Care: Findings from a Nationwide Cross-Sectional Study.

Journal of clinical medicine·2025

Area of Science:

  • Neurology
  • Pain Management
  • Pharmacology

Background:

  • Migraine is a debilitating chronic headache disorder.
  • Current treatments often have significant side effects.
  • Botulinum toxin A is emerging as a novel therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy and safety of botulinum toxin A for migraine prophylaxis.
  • To identify patient subgroups who may benefit most from this treatment.
  • To assess the tolerability and side-effect profile of botulinum toxin A.

Main Methods:

  • Review of retrospective chart reviews and double-blind, placebo-controlled studies.
  • Analysis of efficacy in reducing migraine frequency, severity, and disability.
  • Assessment of safety and tolerability, including comparison with traditional migraine medications.

Main Results:

  • Botulinum toxin A demonstrated significant efficacy in migraine prophylaxis.
  • Consistent reduction in frequency, severity, and disability was observed.
  • High tolerability and safety profile with no reported CNS side effects, organic damage, or allergic complications.

Conclusions:

  • Botulinum toxin A is a safe and effective option for chronic migraine prevention.
  • It is particularly beneficial for patients with muscular stress triggers or concurrent chronic tension-type headaches.
  • The agent offers a favorable alternative to traditional migraine medications due to its safety and tolerability profile.

Related Experiment Videos